R. Nichols

发表

Five-year outcomes from a prospective trial of image-guided accelerated hypofractionated proton therapy for prostate cancer

Zuofeng Li, W. Mendenhall, S. Flampouri, 2017, Acta oncologica.

The History of Proton Therapy in Prostate Cancer

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2017 .

Does Race Influence Health-related Quality of Life and Toxicity Following Proton Therapy for Prostate Cancer?

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2016, American journal of clinical oncology.

Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: Results of two prospective trials

Zuofeng Li, W. Mendenhall, R. Marcus, 2013, Acta oncologica.

Double-scattered proton-based stereotactic body radiotherapy for stage I lung cancer: a dosimetric comparison with photon-based stereotactic body radiotherapy.

Zuofeng Li, S. Flampouri, N. Mendenhall, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Proton therapy for pancreatic cancer.

Zuofeng Li, R. Nichols, M. Rutenberg, 2015, World journal of gastrointestinal oncology.

Protons offer reduced bone marrow, small bowel, and urinary bladder exposure for patients receiving neoadjuvant radiotherapy for resectable rectal cancer.

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2014, Journal of gastrointestinal oncology.

Proton Therapy and Concomitant Capecitabine for Non-Metastatic Unresectable Pancreatic Adenocarcinoma

Zuofeng Li, P. Kelly, S. Sachsman, 2014 .

Rectal toxicity after proton therapy for prostate cancer: an analysis of outcomes of prospective studies conducted at the university of Florida Proton Therapy Institute.

Zuofeng Li, W. Mendenhall, S. Flampouri, 2015, International journal of radiation oncology, biology, physics.

Dosimetric rationale and early experience at UFPTI of thoracic proton therapy and chemotherapy in limited-stage small cell lung cancer

Zuofeng Li, S. Flampouri, C. Morris, 2013, Acta oncologica.

Postoperative proton therapy in the management of stage III thymoma.

S. Flampouri, A. Monroe, B. Hoppe, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Long-term outcomes following proton therapy for prostate cancer in young men with a focus on sexual health

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2018, Acta oncologica.

Salvage of Locally Recurrent Prostate Cancer After Definitive Radiotherapy

W. Mendenhall, N. Mendenhall, B. Hoppe, 2014, American journal of clinical oncology.

Patient-Reported Sexual Survivorship Following High-Dose Image-Guided Proton Therapy for Prostate Cancer.

W. Mendenhall, N. Mendenhall, C. Morris, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Consensus Statement on Proton Therapy for Prostate Cancer

J. Liao, W. Mendenhall, N. Vapiwala, 2021, International journal of particle therapy.

Patient-Reported Quality of Life in Men with Transurethral Resection of the Prostate Undergoing Proton Therapy for Management of Prostate Cancer

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2016, International journal of particle therapy.

Image-Guided Hypofractionated Proton Therapy in Early-Stage Non–Small Cell Lung Cancer: A Phase 2 Study

Zuofeng Li, S. Flampouri, C. Morris, 2020, International journal of particle therapy.

Androgen Deprivation Therapy and Definitive Radiotherapy for Prostate Cancer

W. Mendenhall, N. Mendenhall, B. Hoppe, 2013, American journal of clinical oncology.

Hip fractures and pain following proton therapy for management of prostate cancer

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2013, Acta oncologica.

A phase II trial of escalated dose proton radiotherapy with elective nodal irradiation and concomitant chemotherapy for patients with unresectable, borderline resectable, or medically inoperable pancreatic adenocarcinoma.

C. Morris, B. Hoppe, R. Nichols, 2017 .

Proton radiotherapy for prostate cancer is not associated with post-treatment testosterone suppression.

Zuofeng Li, W. Mendenhall, R. Marcus, 2009, International journal of radiation oncology, biology, physics.

Insurance Approval for Definitive Proton Therapy for Prostate Cancer

W. Mendenhall, N. Mendenhall, C. Morris, 2021, International journal of particle therapy.

Hypofractionated proton therapy with concurrent chemotherapy for locally advanced non-small cell lung cancer: A Phase I trial from the University of Florida and Proton Collaborative Group.

C. Simone, Zuofeng Li, S. Flampouri, 2020, International journal of radiation oncology, biology, physics.

Management of Radiation Proctitis

W. Mendenhall, N. Mendenhall, B. Hoppe, 2014, American journal of clinical oncology.

T2‐T3 carcinoma of the supraglottic larynx: A comparison of surgery and radiotherapy

S. Stringer, W. Mendenhall, W. Lee, 1994 .

Outcomes in men with large prostates (≥ 60 cm3) treated with definitive proton therapy for prostate cancer

Zuofeng Li, W. Mendenhall, L. Mcgee, 2013, Acta oncologica.

Protons offer reduced normal-tissue exposure for patients receiving postoperative radiotherapy for resected pancreatic head cancer.

Zuofeng Li, W. Regine, B. Yi, 2012, International journal of radiation oncology, biology, physics.

When is Elective Pelvic Lymph Node Irradiation Indicated in Definitive Radiotherapy for Localized Prostate Cancer?

W. Mendenhall, N. Mendenhall, B. Hoppe, 2013, American journal of clinical oncology.

Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression

Zuofeng Li, W. Mendenhall, R. Marcus, 2013, Acta oncologica.

Testosterone Replacement Therapy in Men with Prostate Cancer after Proton Therapy

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2014 .

Bacterial Urinary Tract Infection after Transrectal Placement of Fiducial Markers prior to Proton Radiotherapy for Prostate Cancer.

W. Mendenhall, N. Mendenhall, C. Morris, 2016, International journal of particle therapy.

Radiation therapy and concomitant paclitaxel/carboplatin chemotherapy for muscle invasive transitional cell carcinoma of the bladder: A well‐tolerated combination

R. Nichols, N. Dunn, F. Malamud, 2000, International journal of cancer.

Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate Cancer.

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2016, International journal of radiation oncology, biology, physics.

Five- and seven-year outcomes for image-guided moderately accelerated hypofractionated proton therapy for prostate cancer

W. Mendenhall, N. Mendenhall, C. Morris, 2021, Acta oncologica.

Rectal Culture and Sensitivity Analysis for Reducing Sepsis Risk After Fiducial Marker Placement

W. Mendenhall, N. Mendenhall, C. Morris, 2018, American journal of clinical oncology.

Controversies in proton therapy for prostate cancer.

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2016, Chinese clinical oncology.

Protons Safely Allow Coverage of High-Risk Nodes for Patients with Regionally Advanced Non-Small-Cell Lung Cancer

S. Flampouri, N. Mendenhall, Z. Li, 2011, Technology in cancer research & treatment.

Proton radiation therapy offers reduced normal lung and bone marrow exposure for patients receiving dose-escalated radiation therapy for unresectable stage iii non-small-cell lung cancer: a dosimetric study.

Zuofeng Li, Stella Flampouri, Zuofeng Li, 2011, Clinical lung cancer.

Radiation‐induced tumor immunity in patients with non‐small cell lung cancer

P. Okunieff, S. Swarts, Zhen-huan Zhang, 2019, Thoracic cancer.

Hemorrhagic Radiation Cystitis

W. Mendenhall, N. Mendenhall, B. Hoppe, 2015, American journal of clinical oncology.

Proton therapy for prostate cancer.

Zuofeng Li, Zuofeng Li, W. Mendenhall, 2011, Oncology.

Proton beam radiotherapy for pancreas cancer.

R. Nichols, M. Rutenberg, 2020, Journal of gastrointestinal oncology.

Optimizing neoadjuvant radiotherapy for resectable and borderline resectable pancreatic cancer using protons

R. Nichols, M. Rutenberg, 2019, World journal of gastrointestinal surgery.

Feasibility of pancreatectomy following high-dose proton therapy for unresectable pancreatic cancer

K. Hitchcock, S. Hughes, N. Mendenhall, 2017, World journal of gastrointestinal surgery.

Radiation Therapy for Pancreatic Cancer

R. Nichols, 2016 .

Proton therapy may allow for comprehensive elective nodal coverage for patients receiving neoadjuvant radiotherapy for localized pancreatic head cancers.

Zuofeng Li, R. Nichols, M. Ho, 2013, Journal of gastrointestinal oncology.

Proton Therapy With Concurrent Chemotherapy for Thoracic Esophageal Cancer: Toxicity, Disease Control, and Survival Outcomes

Perry B. Johnson, H. Wolfsen, J. Jones, 2022, International journal of particle therapy.

Postoperative or Salvage Proton Radiotherapy for Prostate Cancer After Radical Prostatectomy

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2021, International journal of particle therapy.

Impact of unfavorable factors on outcomes among inoperable stage II-IV Nonsmall cell lung cancer patients treated with proton therapy

S. Flampouri, L. Mcgee, C. Morris, 2019, Acta oncologica.

Sperm preservation and neutron contamination following proton therapy for prostate cancer study

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2017, Acta oncologica.

Image-guided hypofractionated double-scattering proton therapy in the management of centrally-located early-stage non-small cell lung cancer

Zuofeng Li, C. Morris, B. Hoppe, 2020, Acta oncologica.

A Phase 2 Trial of Concurrent Chemotherapy and Proton Therapy for Stage III Non-Small Cell Lung Cancer: Results and Reflections Following Early Closure of a Single-Institution Study.

Zuofeng Li, S. Flampouri, B. McCook, 2016, International journal of radiation oncology, biology, physics.

Feasibility of neurocognitive outcome evaluations in patients with brain metastases in a multi-institutional cooperative group setting: results of Radiation Therapy Oncology Group trial BR-0018.

M. Mehta, F. Schmitt, W. Regine, 2002, International journal of radiation oncology, biology, physics.

Serum Testosterone 60 Months after Passive-Scatter Proton Therapy for Localized Prostate Cancer

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2019, Cancer investigation.

Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on NRG oncology RTOG 9408

Christopher U. Jones, H. Sandler, A. Raben, 2017, Advances in radiation oncology.

Is Radical Prostatectomy the “Gold Standard” for Localized Prostate Cancer?

W. Mendenhall, N. Mendenhall, R. Henderson, 2010, American journal of clinical oncology.

Bacterial Urinary Tract Infection after Fiducial Marker Placement or Prostate Biopsy

W. Mendenhall, N. Mendenhall, B. Hoppe, 2014 .

Neoadjuvant chemoradiation for distal rectal cancer: 5-year updated results of a randomized phase 2 study of neoadjuvant combined modality chemoradiation for distal rectal cancer.

C. Willett, N. Hanna, R. Paulus, 2013, International journal of radiation oncology, biology, physics.

Proton therapy with concomitant capecitabine for pancreatic and ampullary cancers is associated with a low incidence of gastrointestinal toxicity

T. George, N. Mendenhall, H. Asbun, 2013, Acta oncologica.

Particle therapy for pancreatic cancer

R. Nichols, 2015 .

A comparative study of prostate PTV margins for patients using hydrogel spacer or rectal balloon in proton therapy.

W. Mendenhall, N. Mendenhall, B. Hoppe, 2020, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

PTV margin analysis for prostate patients treated with initial pelvic nodal IMRT and prostate proton boost

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2019, Physics in medicine and biology.

Local salvage of radiorecurrent prostate cancer

W. Mendenhall, N. Mendenhall, R. Henderson, 2023, The Prostate.

Proton therapy with concurrent chemotherapy for non-small-cell lung cancer: technique and early results.

Zuofeng Li, S. Flampouri, N. Mendenhall, 2012, Clinical lung cancer.

Rationale and early outcomes for the management of thymoma with proton therapy.

S. Flampouri, B. Hoppe, R. Henderson, 2018, Translational lung cancer research.

Early outcomes from three prospective trials of image-guided proton therapy for prostate cancer.

Zuofeng Li, W. Mendenhall, R. Marcus, 2012, International journal of radiation oncology, biology, physics.

A dosimetric comparison of ultra-hypofractionated passively scattered proton radiotherapy and stereotactic body radiotherapy (SBRT) in the definitive treatment of localized prostate cancer

A. Dritschilo, T. Kole, Binbin Wu, 2015, Acta oncologica.

RE: Takatori K, Terashima K, Yoshida R, Horai A, Satake S, Ose T, Kitajima N, Kinoshita Y, Demizu Y, Fuwa N. Upper gastrointestinal complications associated with gemcitabine-concurrent proton radiotherapy for inoperable pancreatic cancer. J Gastroenterol. 2013; (E-pub only).

B. Hoppe, R. Nichols, 2013, Journal of gastrointestinal oncology.

Proton Therapy as Salvage Treatment for Local Relapse of Prostate Cancer Following Cryosurgery or High-Intensity Focused Ultrasound.

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2016, International journal of radiation oncology, biology, physics.

Proton Therapy as Salvage Treatment for Local Relapse of Prostate Cancer Following Cryosurgery or HIFU

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2013 .

Race Does Not Affect Tumor Control, Adverse Effects, or Quality of Life after Proton Therapy.

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2017, International journal of particle therapy.

Patient-reported Hip Symptoms following Treatment with Proton Therapy for Prostate Cancer

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2013 .

Dose-escalated proton therapy with elective nodal irradiation and concomitant chemotherapy for unresectable, borderline resectable, or medically inoperable pancreatic cancer: a phase II trial.

C. Morris, R. Nichols, M. Rutenberg, 2021, Journal of Gastrointestinal Oncology.

Postprostatectomy Radiotherapy for Prostate Cancer

W. Mendenhall, N. Mendenhall, S. Keole, 2009, American journal of clinical oncology.

Genitourinary Cancers Five-Year Biochemical Results , Toxicity , and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate Cancer

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2022 .

Proton therapy versus photon radiation therapy for the management of a recurrent desmoid tumor of the right flank: a case report

D. Indelicato, R. Marcus, J. Kilkenny, 2012, Radiation oncology.

Pencil beam scanning versus passively scattered proton therapy for unresectable pancreatic cancer.

M. Mehta, Zuofeng Li, K. Langen, 2018, Journal of gastrointestinal oncology.

Five-year outcomes from 3 prospective trials of image-guided proton therapy for prostate cancer.

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2014, International journal of radiation oncology, biology, physics.

Comparative effectiveness study of patient‐reported outcomes after proton therapy or intensity‐modulated radiotherapy for prostate cancer

H. Sandler, M. Regan, M. Sanda, 2014, Cancer.

Feasibility of RNA collection for micro-array gene expression analysis in the treatment of cervical carcinoma: a scientific correlate of RTOG C-0128

D. Gaffney, A. Forbes, J. Ryu, 2005 .

Feasibility of RNA collection for micro-array gene expression analysis in the treatment of cervical carcinoma: a scientific correlate of RTOG C-0128.

D. Gaffney, A. Forbes, J. Ryu, 2004, Gynecologic oncology.

Reduction of prostate intrafraction motion using gas-release rectal balloons.

Zuofeng Li, W. Mendenhall, T. Zhao, 2012, Medical physics.

(S016) Intermediate-risk prostate cancer: a medicare-based cost comparison of five radiotherapy regimens.

W. Mendenhall, N. Mendenhall, B. Hoppe, 2015, Oncology.

Effect of subcutaneous amifostine administration on systolic blood pressure in patients receiving daily fractionated radiotherapy.

R. Nichols, F. Malamud, S. Mahmood, 2004, Journal of Clinical Oncology.

Changes in gene expression induced by chemoradiation in advanced cervical carcinoma: a microarray study of RTOG C-0128.

D. Gaffney, A. Forbes, B. Milash, 2008, Gynecologic oncology.

Erectile Function, Incontinence, and Other Quality of Life Outcomes Following Proton Therapy for Prostate Cancer in Men 60 Years Old and Younger

Zuofeng Li, W. Mendenhall, R. Marcus, 2012, Cancer.

Proton Therapy for Unresectable and Medically Inoperable Locally Advanced Pancreatic Cancer: Results From a Multi-Institutional Prospective Registry

W. Regine, J. Urbanic, S. Apisarnthanarax, 2023, Advances in radiation oncology.

Postprostatectomy Radiotherapy for Prostate Cancer

N. Mendenhall, S. Keole, R. Henderson, 2009, American journal of clinical oncology.

Five-Year Outcomes From a Prospective Trial of Image Guided Accelerated Hypofractionated Proton Therapy for Prostate Cancer

Zuofeng Li, W. Mendenhall, N. Mendenhall, 2015 .

Comparative effectiveness study of patient‐reported outcomes after proton therapy or intensity‐modulated radiotherapy for prostate cancer

H. Sandler, M. Regan, M. Sanda, 2014, Cancer.

Rectal toxicity after proton therapy for prostate cancer: an analysis of outcomes of prospective studies conducted at the university of Florida Proton Therapy Institute.

Zuofeng Li, W. Mendenhall, S. Flampouri, 2015, International journal of radiation oncology, biology, physics.

Implementation of Machine Learning Models to Ensure Radiotherapy Quality for Multicenter Clinical Trials: Report from a Phase III Lung Cancer Study

Z. Liao, A. Berman, H. Willers, 2023, Cancers.

Chemoradiation with Hypofractionated Proton Therapy in Stage II-III Non-Small Cell Lung Cancer: A YYY Phase 1/2 Trial.

C. Simone, L. Kestin, S. Flampouri, 2022, International journal of radiation oncology, biology, physics.